GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BML Inc (OTCPK:BMLKF) » Definitions » Margin of Safety % (DCF Dividends Based)

BML (BMLKF) Margin of Safety % (DCF Dividends Based) : 57.54% (As of May. 22, 2024)


View and export this data going back to 2009. Start your Free Trial

What is BML Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

As of today (2024-05-22), BML's Predictability Rank is 2-Stars. BML's intrinsic value calculated from the Discounted Dividend model is $33.17 and current share price is $12.675. Consequently,

BML's Margin of Safety % (DCF Dividends Based) using Discounted Dividend model is 57.54%.

Competitive Comparison of BML's Margin of Safety % (DCF Dividends Based)

For the Diagnostics & Research subindustry, BML's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BML's Margin of Safety % (DCF Dividends Based) Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BML's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where BML's Margin of Safety % (DCF Dividends Based) falls into.


BML Margin of Safety % (DCF Dividends Based) Calculation

BML's Margin of Safety % (DCF Dividends Based) for today is calculated as

Margin of Safety % (DCF Dividends Based)=(Intrinsic Value: DCF (Dividends Based)-Current Price)/Intrinsic Value: DCF (Dividends Based)
=(29.85-12.675)/29.85
=57.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Dividend model with default parameters.

BML Margin of Safety % (DCF Dividends Based) Related Terms

Thank you for viewing the detailed overview of BML's Margin of Safety % (DCF Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

BML (BMLKF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BML Inc (OTCPK:BMLKF) » Definitions » Margin of Safety % (DCF Dividends Based)
Comparable Companies
TSE:4544 TSE:2395 TSE:2309 TSE:4671 TSE:7707 TSE:3386 TSE:2397 TSE:6090 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX
Traded in Other Exchanges
4694:Japan
Address
5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051
Website
http://www.bml.co.jp
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.